Analyzing brain waveforms using neuroimaging big data helps improve diagnosis accuracy
A team of researchers from Osaka University and The University of Tokyo developed MNet, an automatic diagnosis system for neurological diseases using magnetoencephalography (MEG) (Figure 1), demonstrating the possibility of making automatic neurological disease diagnoses using MEG. Their research results were published in Scientific Reports.
MEG and electroencephalography (EEG) are essential for diagnosing neurological diseases such as epilepsy. MEG allows for the acquisition of detailed temporal-spatial patterns of human brain activity through the measurement of electro-magnetic field associated with neural activity, extracting detailed time-series signals from 160 sensors. Although information obtained from these tests is important for diagnosis, time and expertise are necessary for reading and analyzing, and abnormal waveform patterns may be missed.
Deep Neural Network (DNN), also known as deep learning, is a subset of machine learning in artificial intelligence (AI) and has drawn attention in recent years as a means for classifying data on various images, videos, and sounds at a high accuracy through a machine learning process using big data.
The AI-powered automatic classification system MNet, which utilizes DNN as a computational framework, is based on a neural network called EnvNet (end-to-end convolutional neural network for environmental sound classification) and can be trained to extract and learn features of neuroimaging signals unique to various neurological diseases from a massive amount of time-series neuroimaging data.
The team expected that the use of DNN would allow for the system to learn the characteristics of neurological diseases from many signals and classify patients with neurological diseases more accurately than conventional methods using waveforms.
With MNet, they tried to classify neuroimaging big data on 140 patients with epilepsy, 26 patients with spinal cord injuries, and 67 healthy subjects. The trained MNet succeeded in classifying healthy subjects and those with the two neurological diseases with an accuracy of over 70% and patients with epilepsy and healthy subjects with an accuracy of nearly 90%. The classification accuracy was significantly higher than that obtained by a support vector machine (SVM), a conventional general machine learning method based on waveforms (relative band powers of EEG signal). Moving forward, this technique will be used for diagnosis of various neurological diseases, evaluation of severity, prognosis, and efficacy of treatment.
“Machine learning is constantly advancing, with new techniques being developed all the time. However, no matter how much analytical methods advance, if the quality of underlying data is poor, a sharp distinction cannot be drawn. We carried out the process of machine learning by utilizing DNN, which processed big data mainly from the Osaka University Hospital Epilepsy Center. We’d like to increase the number and the types of diseases to be diagnosed without sacrificing quality of data so that our technique will be helpful in clinical practice,” says researcher Jo Aoe of Osaka University.
The Latest on: Automatic diagnosis system
via Google News
The Latest on: Automatic diagnosis system
- Summit Diagnostics Announces Release of a New Automated Quantitative Urinalysis Solution that Greatly Improves Critical Diagnostic Resultson November 18, 2019 at 5:58 am
This new diagnostic offering will directly provide new advanced analytics resulting in better clinical outcomes. This FDA cleared, patented, and Medicare approved product offering is a quantitative ...
- Global Laboratory Automation Systems Market 2019-2023 | Evolving Opportunities With Agilent Technologies and Danaher | Technavioon November 14, 2019 at 4:21 pm
Technavio has been monitoring the global laboratory automation systems market and the market is poised to grow ... Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
- GenMark Diagnostics to Participate in Upcoming Investor Conferenceson November 13, 2019 at 12:05 pm
CARLSBAD, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the ...
- Automated Microscopy Market Global Insight and Demand 2019on November 11, 2019 at 4:51 am
Automated microscopy is an advance technology that uses advance monitoring techniques such as atomic force microscopy (afm) and raman confocal systems, that enhance monitoring of biological ...
- Experts Reliably Identify EEGs Containing Interictal Epileptiform Discharges for the Diagnosis of Epilepsyon November 8, 2019 at 5:00 am
“Our results establish robust estimates for the reliability of experts for identifying IEDs in routine EEG recordings and provide a basis for evaluating automated IED detection systems,” concluded the ...
- GenMark Diagnostics Reports Third Quarter 2019 Resultson November 6, 2019 at 4:26 pm
CARLSBAD, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results ...
- Chinese scientists develop AI-powered cancer diagnosis systemon October 9, 2019 at 9:50 am
The computer with the CAD system was connected to an endoscopy unit, allowing for fully automated diagnostic assistance during endoscopic examinations. The research team also constructed a cloud-based ...
- An Automatic Diagnostic System of Coronary Artery Lesions Using OCT Imagingon September 25, 2019 at 11:33 am
Become a GOLD or PLATINUM member to access PowerPoint files, presentation audio, and video Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD is ...
- A machine learning framework for automated diagnosis and computer-assisted planning in plastic and reconstructive surgeryon September 19, 2019 at 2:09 am
Although computer-assisted surgical planning systems help to improve clinical outcomes ... and demonstrated its potential for clinical decision making, including fully-automated diagnosis and surgery ...
- Accelerate Diagnostics down 6% premarket on Pheno study resultson September 18, 2019 at 6:30 am
Accelerate Diagnostics (NASDAQ:AXDX) slips 6% premarket on light volume in response to results from clinical studies on its automated antibiotic identification and susceptibility system Accelerate ...
via Bing News